302 related articles for article (PubMed ID: 31822572)
1. Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy.
Camaioni C; Knott KD; Augusto JB; Seraphim A; Rosmini S; Ricci F; Boubertakh R; Xue H; Hughes R; Captur G; Lopes LR; Brown LAE; Manisty C; Petersen SE; Plein S; Kellman P; Mohiddin SA; Moon JC
Heart; 2020 Jun; 106(11):824-829. PubMed ID: 31822572
[TBL] [Abstract][Full Text] [Related]
2. Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging.
Bietenbeck M; Florian A; Shomanova Z; Meier C; Yilmaz A
Clin Res Cardiol; 2018 Nov; 107(11):1062-1070. PubMed ID: 29774406
[TBL] [Abstract][Full Text] [Related]
3. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
4. Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study.
Ismail TF; Hsu LY; Greve AM; Gonçalves C; Jabbour A; Gulati A; Hewins B; Mistry N; Wage R; Roughton M; Ferreira PF; Gatehouse P; Firmin D; O'Hanlon R; Pennell DJ; Prasad SK; Arai AE
J Cardiovasc Magn Reson; 2014 Aug; 16(1):49. PubMed ID: 25160568
[TBL] [Abstract][Full Text] [Related]
5. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
[TBL] [Abstract][Full Text] [Related]
6. Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.
Hughes RK; Camaioni C; Augusto JB; Knott K; Quinn E; Captur G; Seraphim A; Joy G; Syrris P; Elliott PM; Mohiddin S; Kellman P; Xue H; Lopes LR; Moon JC
J Am Heart Assoc; 2021 Aug; 10(15):e020227. PubMed ID: 34310159
[TBL] [Abstract][Full Text] [Related]
7. Validation of pixel-wise parametric mapping of myocardial blood flow with ¹³NH₃ PET in patients with hypertrophic cardiomyopathy.
Sciagrà R; Passeri A; Cipollini F; Castagnoli H; Olivotto I; Burger C; Cecchi F; Pupi A
Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1581-8. PubMed ID: 26121929
[TBL] [Abstract][Full Text] [Related]
8. Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement.
Villa AD; Sammut E; Zarinabad N; Carr-White G; Lee J; Bettencourt N; Razavi R; Nagel E; Chiribiri A
J Cardiovasc Magn Reson; 2016 Jan; 18():4. PubMed ID: 26767610
[TBL] [Abstract][Full Text] [Related]
9. Microvascular Dysfunction in Dilated Cardiomyopathy: A Quantitative Stress Perfusion Cardiovascular Magnetic Resonance Study.
Gulati A; Ismail TF; Ali A; Hsu LY; Gonçalves C; Ismail NA; Krishnathasan K; Davendralingam N; Ferreira P; Halliday BP; Jones DA; Wage R; Newsome S; Gatehouse P; Firmin D; Jabbour A; Assomull RG; Mathur A; Pennell DJ; Arai AE; Prasad SK
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1699-1708. PubMed ID: 30660522
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of global myocardial perfusion reserve assessment based on coronary sinus flow measurements using cardiovascular magnetic resonance in addition to myocardial stress perfusion imaging.
Shomanova Z; Florian A; Bietenbeck M; Waltenberger J; Sechtem U; Yilmaz A
Eur Heart J Cardiovasc Imaging; 2017 May; 18(8):851-859. PubMed ID: 28369259
[TBL] [Abstract][Full Text] [Related]
11. Automated Pixel-Wise Quantitative Myocardial Perfusion Mapping by CMR to Detect Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction: Validation Against Invasive Coronary Physiology.
Kotecha T; Martinez-Naharro A; Boldrini M; Knight D; Hawkins P; Kalra S; Patel D; Coghlan G; Moon J; Plein S; Lockie T; Rakhit R; Patel N; Xue H; Kellman P; Fontana M
JACC Cardiovasc Imaging; 2019 Oct; 12(10):1958-1969. PubMed ID: 30772231
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical significance of cardiovascular magnetic resonance adenosine stress-induced myocardial perfusion defect in hypertrophic cardiomyopathy.
Kim EK; Lee SC; Chang SA; Jang SY; Kim SM; Park SJ; Choi JO; Park SW; Jeon ES; Choe YH
J Cardiovasc Magn Reson; 2020 May; 22(1):30. PubMed ID: 32366254
[TBL] [Abstract][Full Text] [Related]
13. Fully automated, inline quantification of myocardial blood flow with cardiovascular magnetic resonance: repeatability of measurements in healthy subjects.
Brown LAE; Onciul SC; Broadbent DA; Johnson K; Fent GJ; Foley JRJ; Garg P; Chew PG; Knott K; Dall'Armellina E; Swoboda PP; Xue H; Greenwood JP; Moon JC; Kellman P; Plein S
J Cardiovasc Magn Reson; 2018 Jul; 20(1):48. PubMed ID: 29983119
[TBL] [Abstract][Full Text] [Related]
14. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy.
Knaapen P; Germans T; Camici PG; Rimoldi OE; ten Cate FJ; ten Berg JM; Dijkmans PA; Boellaard R; van Dockum WG; Götte MJ; Twisk JW; van Rossum AC; Lammertsma AA; Visser FC
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H986-93. PubMed ID: 18156203
[TBL] [Abstract][Full Text] [Related]
15. Phenotyping hypertrophic cardiomyopathy using cardiac diffusion magnetic resonance imaging: the relationship between microvascular dysfunction and microstructural changes.
Das A; Kelly C; Teh I; Nguyen C; Brown LAE; Chowdhary A; Jex N; Thirunavukarasu S; Sharrack N; Gorecka M; Swoboda PP; Greenwood JP; Kellman P; Moon JC; Davies RH; Lopes LR; Joy G; Plein S; Schneider JE; Dall'Armellina E
Eur Heart J Cardiovasc Imaging; 2022 Feb; 23(3):352-362. PubMed ID: 34694365
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular magnetic resonance detects microvascular dysfunction in a mouse model of hypertrophic cardiomyopathy.
Ku MC; Kober F; Lai YC; Pohlmann A; Qadri F; Bader M; Carrier L; Niendorf T
J Cardiovasc Magn Reson; 2021 May; 23(1):63. PubMed ID: 34053450
[TBL] [Abstract][Full Text] [Related]
17. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
Petersen SE; Jerosch-Herold M; Hudsmith LE; Robson MD; Francis JM; Doll HA; Selvanayagam JB; Neubauer S; Watkins H
Circulation; 2007 May; 115(18):2418-25. PubMed ID: 17452610
[TBL] [Abstract][Full Text] [Related]
18. A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients.
Drakos S; Chatzantonis G; Bietenbeck M; Evers G; Schulze AB; Mohr M; Fonfara H; Meier C; Yilmaz A
Sci Rep; 2021 Aug; 11(1):15667. PubMed ID: 34341436
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.
Chatzantonis G; Bietenbeck M; Florian A; Meier C; Stalling P; Korthals D; Reinecke H; Yilmaz A
Clin Res Cardiol; 2021 Jan; 110(1):136-145. PubMed ID: 32372287
[TBL] [Abstract][Full Text] [Related]
20. Influence of the arterial input sampling location on the diagnostic accuracy of cardiovascular magnetic resonance stress myocardial perfusion quantification.
Milidonis X; Franks R; Schneider T; Sánchez-González J; Sammut EC; Plein S; Chiribiri A
J Cardiovasc Magn Reson; 2021 Mar; 23(1):35. PubMed ID: 33775247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
